Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites.
about
Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 ProvirusBioinformatics and HIV latency.Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1.Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systemsAdvanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometryAmplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites.Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencingAdult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.Integration site and clonal expansion in human chronic retroviral infection and gene therapy.Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization.Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection.High-Throughput Mapping and Clonal Quantification of Retroviral Integration Sites.Transition of adult T-cell leukemia/lymphoma clones during clinical progression.Development of Lentiviral Vectors for Targeted Integration and Protein Delivery.Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy.VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites.Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.
P2860
Q26744327-733C8C3D-C945-4DA4-9169-3A2D089F656AQ28081427-BCB4C6AB-0F78-4405-A1CE-36F7D1EFA2DCQ34983086-0AD8E5D8-D76C-41B9-89E6-DF31E93B69BAQ35110771-7CD7DFD6-B58A-4356-86E1-ABA9D20E888FQ35674201-3576C16B-17A1-4BAE-9BA2-6345A1976199Q35972798-2493F06F-7E24-4826-B784-E28D38D8798AQ36264128-6C04FB1A-ACA1-4C9F-B644-F37FF289C25CQ37731757-7627A1D4-5C94-4C7F-9659-66E734C3ACA1Q38264568-A76BB2A0-074E-4851-A3D0-8799D36CD212Q38683761-A6EA7E99-22AD-4972-B121-C02C4B346AE4Q38867778-4CCD5264-05F2-4FEB-8226-4C6236023DCAQ40267353-4C2D92F6-E944-438D-B744-81D2477ADF28Q40623668-D246FA38-DE69-43BB-81AD-7066098AB64DQ40694300-1DDA44A2-F994-42D5-86AD-9A070813FC52Q45874789-F3471FBE-1CF3-43A0-803F-4FB93663EF2AQ45875081-29682449-A33A-4E42-A594-A2A2FDF0B9B5Q47170880-D6180390-2AA5-4074-A22F-A87E2DA41D66Q53635366-498EF0AA-E14F-4CA6-AB84-F6419AACFF02
P2860
Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development and validation of ...... on provirus integration sites.
@en
Development and validation of ...... on provirus integration sites.
@nl
type
label
Development and validation of ...... on provirus integration sites.
@en
Development and validation of ...... on provirus integration sites.
@nl
prefLabel
Development and validation of ...... on provirus integration sites.
@en
Development and validation of ...... on provirus integration sites.
@nl
P2093
P2860
P356
P1433
P1476
Development and validation of ...... on provirus integration sites.
@en
P2093
Kenta Nakai
Sanaz Firouzi
Sumio Sugano
Tadanori Yamochi
Toshiki Watanabe
Yutaka Suzuki
P2860
P2888
P356
10.1186/GM568
P577
2014-06-27T00:00:00Z
P5875
P6179
1023915778